Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.

Summary: Supports translational research to understand the emergence and trajectory of schizophrenia and related disorders in mid- to late-life, identifying targets for prevention and treatment.

Key Information: Applications must focus on populations aged 35 and older; projects evaluating safety/efficacy or targeting <35 years are not responsive.